90 related articles for article (PubMed ID: 2479631)
1. Mechanisms of immunodominance in T-cell recognition, with applications to vaccine design.
Berzofsky JA
Princess Takamatsu Symp; 1988; 19():161-77. PubMed ID: 2479631
[TBL] [Abstract][Full Text] [Related]
2. Progress toward an artificial vaccine for HIV: identification of helper and cytotoxic T-cell epitopes and methods of immunization.
Berzofsky JA
Biotechnol Ther; 1991; 2(1-2):123-35. PubMed ID: 1726961
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of T cell recognition with application to vaccine design.
Berzofsky JA
Mol Immunol; 1991 Mar; 28(3):217-23. PubMed ID: 1708102
[TBL] [Abstract][Full Text] [Related]
4. A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules.
Sinigaglia F; Guttinger M; Kilgus J; Doran DM; Matile H; Etlinger H; Trzeciak A; Gillessen D; Pink JR
Nature; 1988 Dec 22-29; 336(6201):778-80. PubMed ID: 2462673
[TBL] [Abstract][Full Text] [Related]
5. Antigenic peptide interaction with MHC molecules: implications for the design of artificial vaccines.
Berzofsky JA
Semin Immunol; 1991 Jul; 3(4):203-16. PubMed ID: 1932704
[TBL] [Abstract][Full Text] [Related]
6. Structural features of T-cell recognition: applications to vaccine design.
Berzofsky JA
Philos Trans R Soc Lond B Biol Sci; 1989 Jun; 323(1217):535-44. PubMed ID: 2474171
[TBL] [Abstract][Full Text] [Related]
7. Immunodominant sites of human T cell lymphotropic virus type 1 envelope protein for murine helper T cells.
Kurata A; Palker TJ; Streilein RD; Scearce RM; Haynes BF; Berzofsky JA
J Immunol; 1989 Sep; 143(6):2024-30. PubMed ID: 2528586
[TBL] [Abstract][Full Text] [Related]
8. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
9. The role of MHC- and non-MHC-associated genes in determining the human immune response to malaria antigens.
Riley EM
Parasitology; 1996; 112 Suppl():S39-51. PubMed ID: 8684835
[TBL] [Abstract][Full Text] [Related]
10. Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo: identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein.
Calvo-Calle JM; Hammer J; Sinigaglia F; Clavijo P; Moya-Castro ZR; Nardin EH
J Immunol; 1997 Aug; 159(3):1362-73. PubMed ID: 9233633
[TBL] [Abstract][Full Text] [Related]
11. Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.
Patarroyo ME; Patarroyo MA
Acc Chem Res; 2008 Mar; 41(3):377-86. PubMed ID: 18266328
[TBL] [Abstract][Full Text] [Related]
12. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
13. Pre-erythrocytic malaria vaccine: mechanisms of protective immunity and human vaccine trials.
Nardin E; Zavala F; Nussenzweig V; Nussenzweig RS
Parassitologia; 1999 Sep; 41(1-3):397-402. PubMed ID: 10697892
[TBL] [Abstract][Full Text] [Related]
14. Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus.
Bonaldo MC; Garratt RC; Caufour PS; Freire MS; Rodrigues MM; Nussenzweig RS; Galler R
J Mol Biol; 2002 Jan; 315(4):873-85. PubMed ID: 11812154
[TBL] [Abstract][Full Text] [Related]
15. Protein antigenic structures recognized by T cells: potential applications to vaccine design.
Berzofsky JA; Cease KB; Cornette JL; Spouge JL; Margalit H; Berkower IJ; Good MF; Miller LH; DeLisi C
Immunol Rev; 1987 Aug; 98():9-52. PubMed ID: 2443443
[TBL] [Abstract][Full Text] [Related]
16. A novel Plasmodium falciparum sporozoite and liver stage antigen (SALSA) defines major B, T helper, and CTL epitopes.
Bottius E; BenMohamed L; Brahimi K; Gras H; Lepers JP; Raharimalala L; Aikawa M; Meis J; Slierendregt B; Tartar A; Thomas A; Druilhe P
J Immunol; 1996 Apr; 156(8):2874-84. PubMed ID: 8609407
[TBL] [Abstract][Full Text] [Related]
17. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
[TBL] [Abstract][Full Text] [Related]
18. Permissive recognition of a mycobacterial T-cell epitope: localization of overlapping epitope core sequences recognized in association with multiple major histocompatibility complex class II I-A molecules.
Harris DP; Vordermeier HM; Arya A; Moreno C; Ivanyi J
Immunology; 1995 Apr; 84(4):555-61. PubMed ID: 7790029
[TBL] [Abstract][Full Text] [Related]
19. Immune selection in murine tumors. Ph.d thesis.
Svane IM; Engel AM
APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
[TBL] [Abstract][Full Text] [Related]
20. A cryptic T cell epitope on the apical membrane antigen 1 of Plasmodium chabaudi adami can prime for an anamnestic antibody response: implications for malaria vaccine design.
Amante FH; Crewther PE; Anders RF; Good MF
J Immunol; 1997 Dec; 159(11):5535-44. PubMed ID: 9548494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
